University of Rochester-Golisano Children's Hospital formerly Children's Hospital at Strong, is a nationally ranked, freestanding acute care children's hospital in Rochester, New York. It is affiliated with the University of Rochester School of Medicine and Dentistry.

There are 190 beds in Golisano Children's Hospital.

During the past decade, Golisano Children's Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Golisano Children's Hospital" #1 sponsor was "University of Rochester" with 3 trials, followed by "Aimmune Therapeutics, Inc." with 2 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "Yale University" with 2 trials sponsored and "Children's Hospital of Philadelphia" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Golisano Children's Hospital" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "Maria Fareri Children's Hospital" with 2 trials as a collaborator, "Primary Immune Deficiency Treatment Consortium (PIDTC)" with 2 trials as a collaborator and "Academic Pediatric Association" with 1 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Golisano Children's Hospital" are "Deep Venous Thrombosis" (2 trials), "Peanut Allergy" (2 trials), "ADA SCID" (1 trials), "Acute Kidney Injury" (1 trials) and "Anemia" (1 trials). Many other conditions were trialed in "Golisano Children's Hospital" in a lesser frequency.

Most popular intervention types in "Golisano Children's Hospital" are "Behavioral" (3 trials), "Biological" (3 trials), "Device" (3 trials), "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "AR101" (2 trials), "Enoxaparin" (2 trials), "Audit & Feedback (real time, individual-level)" (1 trials), "Audit & Feedback (unit level)" (1 trials) and "Bracing" (1 trials). Other intervention names were less common.

The vast majority of trials in "Golisano Children's Hospital" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Golisano Children's Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 8 completed trials in Golisano Children's Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Golisano Children's Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".